As parents across the U.S. are scrambling to find baby formula because of supply disruptions, the Food and Drug Administration announced Tuesday it would allow some formula products from the shuttered Abbott facility in Michigan to be released on a “case-by-case” basis.
In February, the FDA warned parents not to use certain popular powdered infant formulas manufactured at Abbott’s Sturgis plant after receiving four reports of infants who were hospitalized with bacterial infections after consuming formula from the facility. Two of the infants died.
Abbott subsequently issued a recall of all potentially affected products manufactured at the facility and the FDA later shut down the plant after federal safety inspectors found Abbott failed to maintain sanitary conditions and procedures at the facility.